Related Experiment Video
Updated: Jun 21, 2025

Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models
Published on: March 21, 2025
Undercover lung damage in pediatrics - a hot spot in morbidity caused by collagenoses
Ancuta Lupu1, Maria Oana Sasaran2, Elena Jechel1
1Mother and Child Medicine Department, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.
Insights
Pediatric collagenoses can severely affect lung function, impacting connective tissue development. This review highlights respiratory involvement and emphasizes interdisciplinary care for better outcomes in children.
Area of Science:
- Rheumatology
- Pediatrics
- Pulmonology
Background:
- Connective tissue, primarily collagen, is crucial for structural integrity.
- Pediatric collagenoses like lupus, scleroderma, and dermatomyositis can cause widespread organ damage.
- Respiratory involvement in pediatric collagenoses is under-documented compared to adults.
Purpose of the Study:
- To review current literature on the pulmonary impact of collagenoses in children.
- To update medical specialists on the pathophysiology, diagnosis, and treatment of pediatric lung involvement.
- To stress the importance of interdisciplinary collaboration in managing these conditions.
Main Methods:
- Narrative review of recent international publications.
- Inclusion of seminal articles on targeted pathologies.
- Synthesis of information on general principles of pulmonary impact.
Main Results:
- Collagen damage in pediatric systemic inflammatory diseases can affect various organs, notably the lungs.
- Pulmonary manifestations include damage to the chest wall, pleura, interstitium, and vasculature.
- Severe and rapidly progressive lung disease can occur, necessitating prompt intervention.
Conclusions:
- Increased awareness and dissemination of knowledge regarding pediatric collagenoses and lung disease are essential.
- Early diagnosis and management are critical due to the potential for severe outcomes.
- Interdisciplinary collaboration among pediatricians, rheumatologists, pulmonologists, and immunologists is vital.
Abstract:
Connective tissue represents the support matrix and the connection between tissues and organs. In its composition, collagen, the major structural protein, is the main component of the skin, bones, tendons and ligaments. Especially at the pediatric age, its damage in the context of pathologies such as systemic lupus erythematosus, scleroderma or dermatomyositis can have a significant negative impact on the development and optimal functioning of the body. The consequences can extend to various structures (e.g., joints, skin, eyes, lungs, heart, kidneys). Of these, we retain and reveal later in our manuscript, mainly the respiratory involvement. Manifested in various forms that can damage the chest wall, pleura, interstitium or vascularization, lung damage in pediatric systemic inflammatory diseases is underdeveloped in the literature compared to that described in adults. Under the threat of severe evolution, sometimes rapidly progressive and leading to death, it is necessary to increase the popularization of information aimed at physiopathological triggering and maintenance mechanisms, diagnostic means, and therapeutic directions among medical specialists. In addition, we emphasize the need for interdisciplinary collaboration, especially between pediatricians, rheumatologists, infectious disease specialists, pulmonologists, and immunologists. Through our narrative review we aimed to bring up to date, in a concise and easy to assimilate, general principles regarding the pulmonary impact of collagenoses using the most recent articles published in international libraries, duplicated by previous articles, of reference for the targeted pathologies.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Cycle: Exhalation
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Breathing

